Navigation Links
Insulet Reports First Quarter 2008 Results
Date:5/13/2008

tes," said Duane DeSisto, Insulet's president and chief executive officer. "To ensure that our operational infrastructure keeps up with demand, we have significantly accelerated the expansion of the Insulet salesforce and now have nationwide coverage. We are also investing in our sales, marketing and customer support infrastructure, including customer support and sampling with our unique Product Demonstration Kit. With OmniPod production up more than 58% in the first four months of the year, we are on track to achieve our business goals, as well as our mission to improve the lives of people with diabetes."

As of March 31, 2008, Insulet's cash and cash equivalents totaled $73.0 million, compared to $94.6 million at December 31, 2007.

Recent Highlights

* As part of the Company's strategy to invest in its sales and marketing

infrastructure in 2008, Insulet significantly expanded its U.S.

salesforce in the first quarter. The salesforce now totals 49

territory managers and covers all 50 states, plus the District

of Columbia.

* Insulet continues to expand its manufacturing capacity, a critical

element of the Company's strategy to increase volume and reduce per

unit production costs. The Company's production capacity reached

95,000 OmniPod devices per month at the end of April 2008, an increase

of approximately 58% compared to December 2007.

* The Company is pursuing a variety of initiatives to further demonstrate

the clinical and functional benefits of the OmniPod System as well as

expand the market for its potential uses. Insulet is supporting the

first clinical trial of the OmniPod System in a hospital setting which

enrolled its first patient in April. In addition, the OmniPod System

was used in a preclinical study conducted by Micromet, Inc. and

presented at the American Association for Cancer Res
'/>"/>

SOURCE Insulet Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
2. Insulet Corporation to Report Fourth Quarter and Full Year 2007 Financial Results on Monday, March 17
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet ... a second US laboratory is to open in Manhattan, Kansas in early October, ... and long-term growth of research and development through collaboration with researchers from Kansas ...
(Date:8/26/2015)... 2015  Platform therapeutic company Symic Biomedical, Inc. ... $1.5M Phase II SBIR grant from the National ... therapeutic agent to reduce arteriovenous fistula (AVF) failures, ... renal disease (ESRD) patients undergoing hemodialysis. The two-year ... and Digestive and Kidney Diseases (NIDDK), will allow ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... Physicians are Most Concerned About Lack of Reimbursement for, ... ... Decision Resources, WALTHAM, Mass., ... and advisory firms for pharmaceutical and,healthcare issues, finds that the ...
... Inc.,(Nasdaq: ATSI ), manufacturer and marketer ... announced completion of the final,feasibility milestone in ... animal feasibility study has been completed with ... on mechanical heart,valve prostheses., (Logo: ...
... Fla., Nov. 3 Catalyst,Pharmaceutical Partners, Inc. (Nasdaq: ... in-licenses, develops and commercializes prescription,drugs for the treatment ... that Patrick J. McEnany, Chief Executive,Officer, will be ... Rodman &,Renshaw 10th Annual Global Investment Conference on ...
Cached Biology Technology:The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 2The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use 3ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results 2ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results 3Catalyst Pharmaceutical Partners to Present at the Rodman & Renshaw 10th Annual Global Investment Conference 2
(Date:8/12/2015)... 12, 2015 As the digital ... innovation and advanced biometrics technology is accelerating beyond expectations.  ... rely on using their credit cards, the digital currency, ... for payment services led by companies in the space ... Google, Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: ...
(Date:8/10/2015)... BOSTON and TELTOW, Germany ... SensoMotoric Instruments (SMI), a world leader in Eye ... the completion of its OEM Eye Tracking Platform for ... Eye Tracking Platform contains reference designs for seamless integration ... kiosk systems, virtual reality HMDs and augmented reality smart ...
(Date:8/6/2015)... 6, 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced collaboration with Microsoft on biometric ... Microsoft leveraged Synaptics, deep expertise in human interface ... Through stringent testing, Synaptics, advanced image ... Microsoft,s Precision TouchPad (PTP) specification empowering OEMs with ...
Breaking Biology News(10 mins):Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 2Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 3Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 4Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 5Digital Wallet Devices & Mobile Payment Management Services Gain a Distinct Advantage in the Digital Payment Evolution as Demand Continues to Grow 6SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... University, RIKEN (The Institute of Physical and Chemical Research, ... Japan) have discovered a way to make the widely ... and less expensive. Hydrogenation is a chemical ... from food products, such as margarine, to petrochemicals and ...
... the sounds in a child,s cough, could soon be ... reliably. According to Udantha Abeyratne from the University of ... recording coughs with a microphone on the patient,s bedside ... childhood pneumonia in remote regions around the world. Their ...
... are well established. Now, researchers at Yonsei University in ... coat glass with a layer of silver ions that ... coli , Salmonella typhimurium and Campylobacter ... medical equipment and be particularly useful for applications in ...
Cached Biology News:Making hydrogenation greener 2Pneumonia revealed in a cough 2Spinning up antibacterial silver on glass 2
ANTI PIG LDH H4...
... Fiberboard boxes are ideal for use in refrigerators, freezers, ... racks. Four vibrant colors allow for color coding to ... liquid nitrogen drainage or promote cool air circulation. Supplied ... holds 100 tubes. Box dimensions: 13 x ...
Recombinant Rhesus Monkey IFN-Alpha...
RABBIT ANTI AMPHOTERIN...
Biology Products: